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SUMMARY
Objective: To evaluate the effects of the progressive increase in body weight on lung 
function by oxygen peripheral saturation, spirometry and maximal respiratory pressures 
in different degrees of obesity. Methods: Cross-sectional study including 140 patients in 
clinical and surgical evaluation for obesity treatment. The selected patients were divided 
into six groups of body mass index (BMI), including a control group of non-obese and a 
subdivision for the morbidly obese into three subgroups. Results: Significant differences 
were demonstrated between the groups regarding oxygen peripheral saturation (SpO2) 
(p ≤ 0.001), forced vital capacity (FVC) (p ≤ 0.002, p ≤ 0.02) and forced expiratory vol-
ume in one second (FEV1) (p ≤ 0.001, p ≤ 0.03) in relative and absolute values, respec-
tively. Group VI (BMI  ≥  50.9 kg/m²) showed significant differences (SpO2, FVC and 
FEV1) when compared with the other groups (except group V) and group V (BMI ≥ 45 
to 49.9 kg/m²) with the group control. The other variables (FEV1/FVC ratio, forced ex-
piratory flow 25-75 [FEF25-75] and maximal respiratory pressure) did not show any sta-
tistical differences. Conclusion: Lung function is influenced by the progressive increase 
in BMI, with changes in lung function better demonstrated when BMI ≥ 45 kg/m²; these 
changes are more evident when BMI > 50.9 kg/m². 
Keywords: Spirometry; respiratory function tests; obesity; morbid obesity; cross-sec-
tional studies; body mass index.
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INTRODUCTION
The alarming worldwide increase in the prevalence of obe-
sity has been a concern to the World Health Organization 
(WHO), being one of the most serious public health prob-
lems in recent years, with threatening projections for the 
21st century1. 
In Brazil, similar to developed countries, the preva-
lence of obesity has shown a significant increase in all age 
groups, especially in the female sex2. Obesity prevention 
and control have been a priority for the WHO due to the 
fact that obesity is a systemic disease associated with vari-
ous comorbidities, being an important independent risk 
factor for chronic diseases (cardiovascular diseases, dia-
betes, musculoskeletal disorders and some cancers), with 
high risk of premature death1,3.
Obesity promotes deterioration of respiratory mechan-
ics by decreasing the chest expansibility due to the increase 
in adipose tissue in the chest wall and abdominal cavity. 
That increases and impairs diaphragmatic mobility, caus-
ing decrease in lung compliance and chest wall, resulting 
in decreased pulmonary volumes and inspiratory muscle 
overload. The decrease in lung ventilation may lead to pe-
ripheral lung occlusion, ventilation-perfusion abnormali-
ties and arterial hypoxemia3-6. 
The worsening in lung function in obese patients is 
associated with increased morbidity and mortality, simi-
lar to other diseases such as cancer, cardiovascular and 
chronic respiratory diseases and heart attack3,4; however, 
very oen the influence of obesity on respiratory disor-
ders goes unrecognized3-6. 
Lung function tests are essential for the management 
of patients with respiratory disorders, as well as those with 
potential to develop them, providing objective data on 
lung function and determining their correlation with the 
patient’s clinical complaints7,8. 
Spirometry is the most frequent and useful lung func-
tion test carried out in clinical practice9. The peripheral 
oxygen saturation (SpO2) performed by pulse oximetry 
is a noninvasive, safe, practical and inexpensive method. 
It is a sensitive indicator of abnormal gas exchange and can 
be used as a screening test for arterial gasometry8,10. 
The respiratory muscle strength assessment through 
maximal respiratory pressure measurement has been in-
corporated into clinical practice. The MIP (maximum 
inspiratory pressure) is an index of diaphragm strength, 
while the MEP (maximal expiratory pressure) measures 
the strength of the abdominal and intercostal muscles6,11,12.
Previous studies of pulmonary function in obese 
patients are limited to assessing functional changes in 
three obese classes, considering the morbidly obese 
(BMI  ≥  40  kg/m²) as a single group, according to the 
WHO classification by BMI (body mass index): under-
weight  ≤  18.5  kg/m²; normal from 18.5 to 24.9  kg/m²; 
overweight: 25 to 29.9  kg/m²; obesity grade I: 30 to 
34.9 kg/m²; obesity grade II : 35 to 39.9 kg/m² and obesity 
grade III ≥ 40 kg/m²)13-15.  
The aim of this study was to evaluate the effects of the 
progressive increase in body weight on lung function by 
spirometry, SpO2, MIP and MEP in different degrees of 
obesity. The group of morbidly obese patients has been 
subdivided into three subgroups to better demonstrate the 
effect of the progressive increase in BMI on the respiratory 
functional variables studied. 
METHODS 
This is a cross-sectional study carried out at the Outpa-
tient Clinic of Universidade Federal de Sergipe (UFS), in 
the city of Aracaju, Sergipe. Data were collected between 
January and December 2007. The study was approved by 
the Ethics Committee in Research of the UFS (CAAE-
0050.0.107.000-07) and a signed free and informed con-
sent form was obtained from all patients. 
The sample was selected among patients undergoing 
clinical and surgical evaluation for the treatment of obesity 
in the obesity outpatient clinics of Hospital São Lucas and 
UFS, where the clinical assessment and lung function tests 
were conducted by an assistant pneumologist. We selected 
a control group of 26 healthy subjects with no respiratory 
symptoms, who had normal lung function according to 
the criteria of the Brazilian Guidelines for Lung Func-
tion Test16, consisting of volunteers (family members and 
friends of patients, healthcare professionals). 
The 140 selected individuals were divided into six 
groups according to BMI level: Group I: 26 (normal weight 
and overweight) with BMI: 18.5 to 29.9 kg/m2; Group II: 
18 individuals (class I obesity) with BMI 30 to 34,9 kg/m2; 
Group III: 24 subjects (class II obesity) with BMI 35 to 
39.9 kg/m2; Group IV: 30 patients (class III obesity) with 
BMI 40 to 44.9 kg/m2; Group V: 23 individuals (class III 
obesity) with BMI 45 to 50.9  kg/m2; Group VI: 19 indi-
viduals (class III obesity) with BMI ≥ 51 kg/m2. 
Patients aged 18 years and older were included. All pa-
tients from the obese group under evaluation for surgical 
treatment of obesity (groups III to VI) had previously tried 
at least three clinical treatments, experiencing failure and 
frustration. They were compensated from the clinical point 
of view with diet and/or drugs and had been approved to 
undergo the surgical treatment of obesity. 
The exclusion criteria were used for patients with acute 
or chronic pulmonary disease, unable to perform the lung 
function tests, those with neuromuscular disease, heart fail-
ure, severe or poorly controlled hypertension, chronic kid-
ney disease, severe systemic disease, systemic corticosteroid 
use, decompensated diabetes mellitus, current smokers or 
former smokers who had smoked more than 10 packs/year. 
Due to medical indication, the obese patients were sub-
mitted to chest x-ray, electrocardiogram, echocardiogram 
and laboratory tests during the preoperative evaluation. 
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Those who had never smoked were considered non-
smokers and ex-smokers those who had stopped smok-
ing for at least six months and had smoked less than 
10 packs/year. Active smokers were those who consumed 
tobacco products at any amount at the time of the study or 
over the last six months. 
Regarding physical activity, individuals were consid-
ered non-sedentary when they performed regular physical 
activity at least three times a week, with a minimum dura-
tion of 30 minutes. Sedentary were considered those who 
did not perform any physical activity or did so for shorter 
periods of time.
Body weight was measured with the individual wear-
ing light clothes and no shoes and height was obtained us-
ing an anthropometer attached to the scale that met the 
criteria for measuring weight of morbidly obese patients. 
BMI was calculated as weight in kilograms divided by 
height in meters squared. 
Aer the patient had been sitting at rest for at least 
ten minutes, SpO2 was measured using a Medical Onyx II 
9500 portable digital oximeter (Nonin, Plymouth, Minne-
apolis, USA) in one of the fingers, without enamel, aer a 
waiting period of at least two minutes until the reading. 
Then, with the patient in the sitting position and using a 
nose clip, lung function tests were sequentially performed: 
MIP, MEP and spirometry.   
The MIP was measured from the residual volume and 
MEP from total lung capacity, with a minimum of five 
maneuvers being performed for each of them and using 
the highest value. The reference equation for the maximal 
respiratory pressures was expressed as a percentage of 
normality for the Brazilian population, according to the 
equation by Neder et al.17; for spirometry, the equation of 
references by Hankinson18 was used, with the maneuvers 
being performed in accordance with current recommen-
dations by the SBPT16. During the spirometric test, forced 
expiratory maneuver was performed at least three times, 
aer which the best one was chosen. 
Spirometry was performed using a computerized spi-
rometer (model Microlab-3500) and maximal respiratory 
pressures using a digital Micro Respiratory Pressure Meter 
manovacuometer (Micro RPM), both from Micro Medical 
Ltd., Kent, UK. 
The variables analyzed were sex, age, ethnicity, height, 
smoking status, BMI, physical activity level, SpO2, MIP, 
MEP (cmH2O), FVC, FEV1, FEF25-75, FEV1/FVC ratio, 
in absolute  and relative values. 
Statistical analysis was performed using the Statistical 
Package for Social Sciences, release 13 (SPSS Inc., Chicago, 
IL, USA). Continuous variables were described as mean 
and standard deviation and categorical variables were 
summarized by means of simple and relative frequencies, 
and the Chi-square or Fisher’s exact test was used as ap-
propriate. The comparison between the different BMI cat-
egories was performed using one-way ANOVA followed 
by Tukey’s post-test and calculation of 95% CI. Two-tailed 
tests were used and the level of statistical significance was 
set at p < 0.05. 
RESULTS 
A total of 140 patients with a mean age of 36.4 ± 11.2 years 
was evaluated, ranging from 18 to 63 years, of which 84 
(60.0%) were females. Regarding ethnicity, 74 (52.9%) 
were Caucasians. The mean BMI was 39.91 ± 10.57 kg/m² 
(range 19.3 to 65.6  kg/m²), with a significant difference 
between the groups (p < 0.001). The groups had a homo-
geneous distribution regarding sex, age, ethnicity, height, 
smoking status and physical activity (Table 1).  
Table  2 compares the spirometric variables, maximal 
respiratory pressures and oxygen saturation in the six 
groups. The mean SpO2 was 97.18 ± 1.6%, ranging from 
89% to 100%, with a significant difference between the 
groups (p ≤ 0.001). 
Group VI showed lower SpO2 with significant dif-
ferences with the other groups (group I: p ≤  0.006 and 
95% CI: 0.9 to 3.4, group II: p ≤ 0.01 and 95% CI: 0.2 to 
3.0; group III: p ≤ 0.02 and 95% CI: 0.2 to 2.8), except for 
group V, which showed lower SpO2, with significant differ-
ences with groups I (p ≤ 0.004 and 95% CI: 0.6 to 3.0) and 
IV (p ≤ 0.003 and 95% CI: 0.03 to 2.4). Group IV showed 
a homogeneous distribution with groups I, II and III (Ta-
ble 2, Figure 1). 
The mean FVC was 3.72 ± 0.87 liters in absolute val-
ues, ranging from 1.74 to 5.97 liters and in relative values, 
88.97 ± 0.12%, ranging from 48% to 119%. As for FEV1, 
the mean absolute value was 3.03 ± 0.72 L, ranging from 
1.34 to 5.36 L and the relative value was 88.55 ± 11.41%, 
ranging from 51% to 119%. 
The groups showed statistical differences regarding 
the mean FVC in absolute and relative values  (p ≤ 0.02, 
p ≤ 0.002, respectively), with a progressive reduction in 
FVC between the groups. Regarding absolute values 
of FVC, only Group I was superior to Group VI (p ≤ 0.008 
and 95% CI: 0.15 to 1.63). As for relative values  of FVC, 
Group VI was statistically lower than the groups: I 
(p ≤ 0.001 and 95% CI: 10.4 to 29.4), Group II (p ≤ 0.006 
and 95% CI: 2.6 to 23.3), Group III (p ≤ 0.006 and 95%  
CI: 2.4 to 21.7) and Group IV (p ≤ 0.003 and 95% CI: 3.0 
to 21.4). Group V was statistically lower than Group I 
(p ≤ 0.005 and 95% CI: 2.3 to 20.4) (Table 2, Figure 1). 
The mean values of FEV1 differed significantly 
between the groups in absolute and relative values 
(p ≤ 0.03, p ≤ 0.001, respectively), with a progressive de-
crease in FEV1 between the groups. In absolute FEV1 
values, only Group I was statistically higher than Group 
VI (p ≤ 0.01 and 95% CI: 0.09 to 1.34). It was also ob-
served that relative values  in Group VI were statistically 
lower than the groups: I (p ≤ 0.001 and 95% CI: 8.9 to 27), 
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II (p ≤ 0.03 and 95% CI: 3.1 to 22, 8), III (p ≤ 0.01 and 
95% CI: 1.7 to 20.1) and IV (p ≤ 0.002 and 95% CI: 3.0 
to 20.6). Group V was statistically lower than Group I 
(p ≤ 0.03 and 95% CI: 0.52 to 17.6) (Table 2, Figure 1). 
With respect to maximal respiratory pressures, the 
mean MIP in absolute values  was 105.79 ± 27.10 cmH2O, 
ranging from 50 to 196 cmH2O and as for relative values, 
a mean of 118.37  ±  31.41% was demonstrated, ranging 
from 53.02% to 218.51%. The MEP showed a mean value 
of 129.15  ±  32.97  cmH2O for absolute values , ranging 
from 60 to 254 cmH2O and for relative values, a mean of 
118.82 ± 26.94% was demonstrated, ranging from 58.72% 
to 209.57%.  
The groups had a homogeneous distribution regard-
ing FEV1/FVC ratio, FEF25-75, MEP and MIP (abso-
lute and relative values), with no significant differences 
(Table 2). 
DISCUSSION
Previous studies evaluating lung function in obesity 
have generally considered the morbidly obese as a single 
group and only assessed lung function alterations in two 
Table 1 – Distribution of demographic characteristics, physical activity and smoking status, stratified by BMI
Variable  
    (n)
G I  
(26)
G II  
(18)
G III  
(24)
G IV  
(30)
G V  
(23)
G VI  
(19)
p
Gender1 n (%)
Male 14 (53.8) 6 (33.3) 8 (33.3) 10 (33.3) 10 (43.5) 8 (42.1) 0.61
Female 12 (46.2) 12 (66.7) 16 (66.7) 20 (66.7) 13 (56.5) 11 (57.9)
Age (years)2 34.3 ± 11.7 42.6 ± 12.6 35.6 ± 11.2 35.1 ± 9.8 34.6 ± 10.7 39.2 ± 10.5 0.12
Ethnicity1            
Caucasian 14 (53.8) 8 (44.4) 14 (58.3) 18 (60.0) 11 (47.8) 9 (47.4) 0.86
Non-Caucasian 12 (46.2) 10 (55.6) 10 (41.7) 12 (40.0) 12 (52.2) 10 (52.6)
Height (meters)2 1.66 ± 0.08 1.65 ± 0.07 1.65 ± 0.10 1.65 ± 0.08 1.67 ± 0.08 1.65 ± 0.11 0.99
Smoking status3            
No smoker n (%) 25 (96.2) 12 (66.7) 18 (75.0) 19 (63.3) 18 (78.3) 14 (73.7) 0.06
Ex-smoker n (%) 1 (3.8) 6 (33.3) 6 (25.0) 11 (36.7) 5 (21.7) 5 (26.3)
Physical activity3            
Sedentary n (%) 19 (73.1) 13 (72.2) 18 (75.0) 26 (86.7) 20 (87.0) 17 (89.5) 0.49
Non-sedentary n (%) 7 (26.9) 5 (27.8) 6 (25.0) 4 (13.3) 3 (13.0) 2 (10.5)
BMI, body mass index; values expressed in means ± SD. Pearson’s chi-square test1. One-way ANOVA test, Tukey’s test2. Fisher’s exact test3.
Variable 
    (n)
G I 
(26)
 G II 
(18)
G III 
(24)
G IV 
(30)
G V 
(23)
G VI 
(19)
p
FEV1, L
FEV1 % 
3.39 ± 0.72
95.7 ± 10.5
2.88 ± 0.43
90.6 ± 9.7
3.02 ± 0.78
88.5 ± 11.8
3.05 ± 0.67
89.5 ± 9.8
3.06 ± 0.69
86.5 ± 9.5
2.67 ± 0.76
77.6 ± 10.4
0.03
0.001
FVC, L
FVC %
4.18 ± 0.86
97.4 ± 12.5
3.56 ± 0.57
90.5 ± 10.4
3.72 ± 0.85
89.5 ± 9.9
3.73 ± 0.81
89.7 ± 9.2
3.70 ± 0.90
86.1 ± 11.7
3.20 ± 0.99
77.5 ± 11.1
0.02
0.002
FEV1/FVC % 81.1 ± 5.8 81.2 ± 6.6 80.9 ± 4.3 82.0 ± 4.9 83.1 ± 5.3 81.7 ± 5.0 0.72
FEF25-75, L/s
FEF 25 / 75 %
3.60 ± 1.22
97.4 ± 23.4
3.57 ± 1.32
107.9 ± 32.9
3.29 ± 1.20
92.2 ± 22.0
3.47 ± 0.94
98.6 ± 22.7
3.61 ± 0.95
100.2 ± 22.2
3.02 ± 0.88
88.8 ± 21.8
0.45
0.21
MEP 126.5 ± 39.3 120.2 ± 27.6 127.4 ± 32.4 131.1 ± 21.5 131.5 ± 41.8 137.6 ± 33.8 0.70
MEP % 108.6 ± 29.4 119.1 ± 30.8 120.0 ± 29.9 123.1 ± 19.0 116.4 ± 26.8 127.2 ± 25.2 0.26
MIP 102.4 ± 27.4 98.6 ± 19.6 105.1 ± 26.3 107.9 ± 23.8 109.4 ± 29.8 110.5 ± 35.6 0.73
MIP % 114.0 ± 34.1 117.4 ± 31.5 115.7 ± 28.5 118.4 ± 25.6 121.0 ± 33.7 125.4 ± 38.5 0.88
SpO2 98.1 ± 0.9 97.6 ± 1.4 97.4 ± 1.1 97.5 ± 0.9 96.3 ± 2.1 95.9 ± 2.1 0.001
Data expressed as absolute and relative values. Variables expressed as means ± sd. One-way ANOVA, Tukey’s Test. BMI, body mass index.
Table 2 – Evaluation of spirometric variables, maximal respiratory pressures and oxygen peripheral saturation between the 
groups, stratified by BMI
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Figure 1 – Distribution of mean values and 95% CI of SpO2, FEV1, FVC, MEP, MIP in relative values, between the groups, 
in the sample. 
SpO2, peripheral oxygen saturation; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; MEP, maximum 
expiratory pressure; MIP, maximum inspiratory pressure.
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or three classes of obesity, without respiratory functional 
evaluation over all classes of obese individuals6,13-15,19-21. 
In this study, we aimed at demonstrating pulmonary 
function impairment secondary to the progressive increase 
in body weight in six BMI groups. We kept the WHO clas-
sification of obesity until the BMI ≤ 40 kg/m2; however, to 
differentiate our study from those previously reported, we 
established a control group of non-obese individuals and 
subdivided the group of morbidly obese patients into three 
subgroups, thus being able to observe the progressive im-
pairment of respiratory function as BMI rises. 
Our results demonstrated an inverse relationship be-
tween BMI and the respiratory functional variables stud-
ied, with a modest effect on lung function up to a BMI 
≤ 45 kg/m², noting that Group IV (BMI 40 to 44.9 kg/m²) 
presented characteristics of respiratory function more 
similar to Groups II and III (obesity grade I and II) than 
the morbidly obese Groups V and VI (BMI ≥ 45 kg/m²).  
Significant alterations in lung function were observed 
only when the BMI exceeded 45 kg/m², increasing when 
the BMI reached values  above 50.9 kg/m², characterizing 
the group of morbidly obese patients as a heterogeneous 
group in terms of respiratory function, justifying its subdi-
vision into subgroups for the assessment of lung function. 
These alterations differ from previous studies, which re-
ported minimal changes in respiratory function up to the 
BMI ≤ 40 kg/m²; however, in these studies, the group of 
morbidly obese patients has always been considered as a 
single group (BMI ≥ 40 kg/m2)3,6,19,22. 
In recent years, there has been a marked increase in 
the number of obese patients undergoing surgical treat-
ment of obesity. The good performance of inspiratory and 
expiratory muscles in the postoperative period of these pa-
tients is essential for the cough reflex and an adequate and 
effective tracheobronchial cleaning, contributing to good 
pulmonary oxygenation and ventilation2,23,24. 
There are controversies in the literature on the effect of 
obesity on maximal respiratory pressures6,11,12. Some stud-
ies state that the maximal respiratory pressures are usually 
normal in healthy individuals, in several degrees of obe-
sity and particularly in morbidly obese individuals in the 
sitting position6,11,25. The reason is that obese individuals 
compensate for the respiratory load by doubling the re-
spiratory effort and diaphragmatic pressure, increasing the 
contribution of the rib cage in the respiratory movement, 
by performing rapid and shallow breaths11. 
With an opposing view, Poulain et al.26 reported that 
respiratory muscle strength may be impaired in obesity, 
with reduced maximal inspiratory pressure in the obese 
when compared with the non-obese control group, as a 
consequence of reduced chest wall compliance or lower 
lung volumes or both.
The results of the present study showed normal maxi-
mal respiratory pressures, with an upward trend as the 
BMI increases, although with a homogeneous distribution 
in the studied groups.
One limitation of a cross-sectional study such as this 
one is the lack of observation over time, not allowing de-
termining prognostic considerations on the various sub-
groups of obese individuals. 
CONCLUSION
In conclusion, lung function is influenced by the progres-
sive increase in BMI, with changes in lung function being 
better demonstrated when BMI ≥ 45 kg/m²; these changes 
in lung function are more evident when BMI > 50.9 kg/m². 
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